Adenocarcinoma of the esophagogastric junction in Japan

Hepato-Gastroenterology

Volumn 55, Issue 81, 2008, Pages 103-107

  Yamamoto, Manabu ^a,c   Baba, Hideo ^b   Egashira, Akinori ^a   Oki, Eiji ^a   Ikebe, Masahiko ^a   Kakeji, Yoshihiro ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

Author keywords

Adenocarcinoma; Esophagogastric junction; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL CARCINOMA; HUMAN; INDEPENDENT VARIABLE; JAPAN; LOWER ESOPHAGUS SPHINCTER ADENOCARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

ADENOCARCINOMA; AGE FACTORS; AGED; ESOPHAGECTOMY; ESOPHAGOGASTRIC JUNCTION; FEMALE; GASTRECTOMY; HUMANS; JAPAN; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PANCREATECTOMY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SPLENECTOMY; STOMACH NEOPLASMS;

EID: 41549091793     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr: Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265:1287-1289.
2. Powell J, McConney CC: Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer 1990; 62:440-443.
3. Reed PI: Changing pattern of esophageal cancer. Lancet 1991; 338:178.
4. Ohno S, Tomisaki S, Oiwa H, Sakaguchi Y, Ichiyoshi Y, Maehara Y, Sugimachi K: Clinicopathologic characteristics and outcome of adenocarcinoma of the human gastric cardia in comparison with carcinoma of other regions of the stomach. J Am Coll Surg 1995; 180:577-582.
5. Siewert JR, Stein HJ: Carcinoma of the gastroesophageal junction-classification, pathology and extent of resection. Dis Esoph 1996; 9:173-182.
6. Siewert JR, Hölscher AH, Becker K, Gössner W: Kardiakarzinom:Versuch einer therapeutisch relevanten Klassifikation. Chirurgie 1987; 58:25-34.
7. Siewert JR, Stein HJ: Classification of carcinoma of the oesophagogastric junction. Br J Cancer 1998; 85:1457-1459.
8. Sobin LH, Wittekind S: International Union Against Cancer (UICC). TNM Classification of Malignant Tumors. 5th Edition. New York: John Wiley & Sons, 1997.
9. Fleming ID: American Joint Committee on Cancer Classification (AJCC), AJCC Cancer Staging Manual. Philadelphia: Lippincott Williams & Wilkins, 1997.
10. Cox DR: Regression models and life tables (with discussion). J R Stat Soc B 1972; 35:187-220.
11. Blomjous JG, Hop WC, Langenhorst BL, ten Kate FJ, Eykenboom WM, Tilanus HW: Adeocarcinoma of the gastric cardia. Recurrence and survival after resection. Cancer 1992; 70:569-574.
12. Stipa S, Giorgio A, Ferri M: Surgical treatment of the gastric cardia. Surgery 1995; 111:386-389.
13. Mäkelä JT, Juvonen T, Laitinen S, Kairaluoma MI: Adenocarcinoma of the gastric cardia. Surg Oncol 1995; 4:75-81.
14. Hagen JA, Peters JH, DeMeester TR: Superiority of extended en bloc esophagectomy for carcinoma of the lower esophagus and cardia. J Thorac Cardiovasc Surg 1993; 106:850-858.
15. Hölscher AH, Bollschweiler E, Siewert JR: Carcinoma of the gastric cardia. Ann Chir Gynecol 1995; 84:185-192.
16. Siewert JR, Böttcher K, Roder JD, Busch R, Her manek P, Meyer HJ: Prognostic relevance of systemic lymph node dissection in gastric carcinoma. Br J Surg 1993; 80:1015-1018.
17. Siewert JR, Feith M, Werner M, Stein HJ: Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1002 consecutive patients. Ann Surg 2000; 232:353-361.
18. Sano T, Sasako M, Yamamoto S, Nashimoto A, Kurata A, Hiratsuka M, Tsujinaka T, Kinoshita T, Arai K, Yamamura Y, Okajima K: Gastric cancer surgery: morbidity and mortality results from a prospective randomized control trial comparing D2 and extended para-aorta lymphadenectomy-Japan clinical oncology group study 9501. J Clin Oncol 2004; 22(14):2767-2773.
19. Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, Welvaart K, van Krieken JH, Meijer S, Plukker JT, van Elk PJ, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H, Sasako M: Extended lymph node dissection for gastric cancer: Who may benefit? Final results of randomized dutch gastric cancer group trial. J Clin Oncol 2004; 22(11):2069-2077.
20. Schwarz RE, Smith DD: Extended lymph node dissection for gastric cancer: Who may benefit? Final results of randomized Dutch gastric cancer group trial. J Clin Oncol 2004; 22(23):5404.
21. Wang LD, Shi ST, Zhou Q, Goldstein S, Hong JY, Shao P, Qiu SL, Yang CS: Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal gastric-cardia carcinogenesis. Int J Cancer 1994; 15:514-519.